Researchers have developed a manganese-based magnetic resonance imaging contrast agent, a potential alternative to gadolinium-based agents, which carry significant health risks for some patients.
Researchers have developed a manganese-based magnetic resonance imaging contrast agent, a potential alternative to gadolinium-based agents, which carry significant health risks for some patients.